Related Experiment Video
Updated: Dec 8, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure
Katherine E Odegaard1, Victoria L Schaal1, Alexander R Clark1
1Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Insights
Opioid exposure during and after pregnancy, including oxycodone, harms offspring neurodevelopment and behavior across generations. This preclinical study reveals lasting anxiety and social deficits, highlighting risks for future generations.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Opioid abuse during and after pregnancy is a growing public health issue.
- Previous research indicates prenatal opioid exposure impairs offspring neurodevelopment.
- Limited understanding exists regarding comparative developmental effects of in utero versus postnatal opioid exposure and hereditary influences.
Purpose of the Study:
- To investigate the comparative neurodevelopmental and behavioral effects of oxycodone exposure in utero (IUO) and postnatally (PNO) in a rat model.
- To examine the intergenerational impact of such exposures.
- To identify underlying molecular mechanisms, including gene expression changes.
Main Methods:
- Utilized a preclinical rat model for oxycodone exposure during gestation and lactation.
- Conducted RNA sequencing to analyze gene expression alterations in exposed offspring across two generations.
- Performed behavioral studies to assess neurodevelopmental and behavioral outcomes, including anxiety and social deficits.
- Validated gene expression changes using RT-PCR.
Main Results:
- Observed significant phenotypic changes in offspring exposed to oxycodone IUO and PNO, across both the first and second generations.
- RNA sequencing revealed significant alterations in the expression of key synaptic genes in exposed offspring.
- Identified differential expression of neuropeptides within the hypocretin system, implicated in addiction.
- Behavioral assessments showed persistent anxiety-like behaviors and social deficits in exposed offspring, extending to subsequent generations.
Conclusions:
- Oxycodone exposure during and after pregnancy disrupts neurodevelopment in offspring.
- These disruptions manifest as lasting behavioral deficits, including anxiety and social impairments.
- The effects are intergenerational, impacting subsequent generations.
- This study identifies the hypocretin system as a potential molecular target for understanding opioid-induced neurodevelopmental and behavioral changes.
Abstract:
Prescription opioid abuse during and after pregnancy is a rising public health concern. While earlier studies have documented that offspring exposed to opioids in utero have impaired neurodevelopment, a significant knowledge gap remains in comparing the overall development between offspring exposed in utero and postnatally. Adding a layer of complexity is the role of heredity in the overall development of these exposed offspring. To fill in these important knowledge gaps, the current study uses a preclinical rat model mimicking oxycodone (oxy) exposure in utero (IUO) and postnatally (PNO) to investigate comparative and intergenerational effects in the two different treatment groups. While significant phenotypic attributes were observed with the two treatments and across the two generations, RNA sequencing revealed alterations in the expression of key synaptic genes in the two exposed groups in both generations. RNA sequencing and post validation of genes using RT-PCR highlighted the differential expression of several neuropeptides associated with the hypocretin system, a system recently implicated in addiction. Further, behavior studies revealed anxiety-like behaviors and social deficits that persisted even in the subsequent generations in the two treatment groups. To summarize, our study for the first time reveals a new line of investigation on the potential risks associated with oxy use during and after pregnancy, specifically the disruption of neurodevelopment and intergenerational impact on behavior.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
05:55Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
Published on: June 17, 2025
Related Concept Videos
Teratogenicity
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Analgesia and Pain Management
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections